Development of Highly Potent and Selective Steroidal Inhibitors and Degraders of CDK8.

Hatcher, John M; Wang, Eric S; Johannessen, Liv; Kwiatkowski, Nicholas; Sim, Taebo; Gray, Nathanael S

Hatcher, John M; Wang, Eric S; Johannessen, Liv; Kwiatkowski, Nicholas; Sim, Taebo; Gray, Nathanael S.

Afiliação

Hatcher JM; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, United States.
Wang ES; Department of Biological Chemistry & Molecular Pharmacology, Harvard Medical School, 360 Longwood Avenue, Longwood Center LC-2209, Boston, Massachusetts 02115, United States.
Johannessen L; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, United States.
Kwiatkowski N; Department of Biological Chemistry & Molecular Pharmacology, Harvard Medical School, 360 Longwood Avenue, Longwood Center LC-2209, Boston, Massachusetts 02115, United States.
Sim T; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, United States.
Gray NS; Department of Biological Chemistry & Molecular Pharmacology, Harvard Medical School, 360 Longwood Avenue, Longwood Center LC-2209, Boston, Massachusetts 02115, United States.

ACS Med Chem Lett ; 9(6): 540-545, 2018 Jun 14.

Article em En | MEDLINE | ID: mdl-29937979

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: ACS Med Chem Lett Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google